ヒトマイクロバイオームの世界市場:製品別(プロバイオティクス、プレバイオティクス、食品、医療食品、診断検査および薬物)、用途別(治療、診断)、疾患別(感染症、炎症性疾患、内分泌および代謝障害、癌およびその他の疾患)、技術別( ゲノミクス、プロテオミクス、メタボロミクス)

◆英語タイトル:Global Human Microbiome Market Size study, by Product (Probiotics, Prebiotics, Foods, Medical Foods, Diagnostic Tests and Drugs), By Application (Therapeutics and Diagnostics), By Disease (Infectious Diseases, Inflammatory Diseases, Endocrine & Metabolic Disorders, Cancer and Other Diseases), By Technology (Genomics, Proteomics and Metabolomics) and Regional Forecasts 2019-2026
◆商品コード:BZW9DC023
◆発行会社(リサーチ会社):Bizwit Research & Consulting
◆発行日:2019年11月28日
◆ページ数:約150
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、日本、アメリカ、カナダ、イギリス、ドイツ、フランス、中国、インド、ブラジル、メキシコ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,650 ⇒換算¥497,550見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥668,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research & Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research & Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

当調査レポートでは、ヒトマイクロバイオームの世界市場について調査・分析し、エグゼクティブサマリ-、定義・範囲、市場動向、市場分析、製品別(プロバイオティクス、プレバイオティクス、食品、医療食品、診断検査および薬物)分析、用途別(治療、診断)分析、疾患別(感染症、炎症性疾患、内分泌および代謝障害、癌およびその他の疾患)分析、技術別( ゲノミクス、プロテオミクス、メタボロミクス)分析、地域別分析、競合状況、調査プロセスなどを含め以下の構成でお届けします。
・エグゼクティブサマリ-
・ヒトマイクロバイオームの定義・範囲
・ヒトマイクロバイオーム市場動向
・ヒトマイクロバイオーム市場分析
・ヒトマイクロバイオームの世界市場:製品別(プロバイオティクス、プレバイオティクス、食品、医療食品、診断検査および薬物)
・ヒトマイクロバイオームの世界市場:用途別(治療、診断)
・ヒトマイクロバイオームの世界市場:疾患別(感染症、炎症性疾患、内分泌および代謝障害、癌およびその他の疾患)
・ヒトマイクロバイオームの世界市場:技術別( ゲノミクス、プロテオミクス、メタボロミクス)
・ヒトマイクロバイオームの世界市場:地域別分析
・競合状況
・調査プロセス
【レポートの概要】

Global Human Microbiome Market is valued approximately at USD 291.08 million in 2018 and is anticipated to grow with a healthy growth rate of more than 25% over the forecast period 2019-2026. Human microbiome can be defined as the aggregate of all microbiota which resides on or inside human tissues and biofluids coupled with the corresponding anatomical sites in which they reside, comprising the skin, uterus, mammary glands, conjunctiva, ovarian follicles, biliary tract, placenta, seminal fluid, lung, saliva, oral mucosa, and gastrointestinal tract. Human microbiome consists of bacteria, fungi, viruses, protists and archaea. Also, a human body harbors microorganism having a ratio of 3:1 as contrasted to the number of human cells present. The relationship of most microbes with the human bodies varies from being mutualistic and commensal to neutral and harmful. Rising incidences of chronic diseases such as cancer, crohn’s syndrome and bowel syndrome along with advancements in the field of microscopic research on human health are the few factors responsible for high CAGR of the market over the forecast period. For instance, In 2018, it was estimated that there were 9.5 million cancer deaths and 17.0 million new cancer cases worldwide. The global burden of cancer is expected to grow to 27.5 million new cancer cases and 16.3 million cancer deaths by 2040 due to the growth and aging of the population, according to the International Agency for Research on Cancer (IARC). Thus, the prevalence of chronic disease is on surging trend across the globe thereby, the need for human microbiome is also increased as it is proved as effective to defend the chronic diseases as well as facilitates a healthy immune system through which the market is growing at significant rate. Moreover, investigational new drug requirements for fecal microbiota aided with growing number of collaborations among market players is the major factor likely to offer lucrative growth opportunity to the market in the upcoming years. However, a lack of expertise as well as barriers in proving the causal link between dysbiosis and diseases are few factors anticipated to hampering the growth of global Smart Water Metering market during the forecast period.

The regional analysis of global Human Microbiome Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world as well as anticipated to exhibit at highest growth rate / CAGR over the forecast period 2019-2026. Factors such as the increasing prevalence of chronic diseases, rising awareness among people on preventive healthcare, high availability of funding for microbiome research, and rising acceptance of probiotic products thereby, impelling the demand for human microbiome across the world.

Major market player included in this report are:
Enterome Bioscience
Seres Therapeutics
4D Pharma PLC
Ubiome, Inc.
E.I. Du Pont De Nemours and Company
Synlogic
Second Genome
Vedanta Biosciences, Inc.
Ferring Pharmaceuticals
Evelo Biosciences, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:
Probiotics
Prebiotics
Foods
Medical Foods
Diagnostic Tests
Drugs

By Application:
Therapeutics
Diagnostics

By Disease:
Infectious Diseases
Inflammatory Diseases
Endocrine & Metabolic Disorders
Cancer
Other Diseases

By Technology:
Genomics
Proteomics
Metabolomics

By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026
Target Audience of the Global Human Microbiome Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Million)
1.2.1. Human Microbiome Market, by Product, 2017-2026 (USD Million)
1.2.2. Human Microbiome Market, by Application, 2017-2026 (USD Million)
1.2.3. Human Microbiome Market, by Disease, 2017-2026 (USD Million)
1.2.4. Human Microbiome Market, by Technology, 2017-2026 (USD Million)
1.2.5. Human Microbiome Market, by Region, 2017-2026 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Human Microbiome Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Type Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Human Microbiome Market Dynamics
3.1. Human Microbiome Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Human Microbiome Market Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Human Microbiome Market, by Product
5.1. Market Snapshot
5.2. Global Human Microbiome Market by Product, Performance – Potential Analysis
5.3. Global Human Microbiome Market Estimates & Forecasts by Product 2016-2026 (USD Million)
5.4. Human Microbiome Market, Sub Segment Analysis
5.4.1. Probiotics
5.4.2. Prebiotics
5.4.3. Foods
5.4.4. Medical Foods
5.4.5. Diagnostic Tests
5.4.6. Drugs
Chapter 6. Global Human Microbiome Market, by Application
6.1. Market Snapshot
6.2. Global Human Microbiome Market by Type, Performance – Potential Analysis
6.3. Global Human Microbiome Market Estimates & Forecasts by Type 2016-2026 (USD Million)
6.4. Human Microbiome Market, Sub Segment Analysis
6.4.1. Therapeutics
6.4.2. Diagnostics
Chapter 7. Global Human Microbiome Market, by Disease
7.1. Market Snapshot
7.2. Global Human Microbiome Market by Disease, Performance – Potential Analysis
7.3. Global Human Microbiome Market Estimates & Forecasts by Disease 2016-2026 (USD Million)
7.4. Human Microbiome Market, Sub Segment Analysis
7.4.1. Infectious Diseases
7.4.2. Inflammatory Diseases
7.4.3. Endocrine & Metabolic Disorders
7.4.4. Cancer
7.4.5. Other Diseases
Chapter 8. Global Human Microbiome Market, by Technology
8.1. Market Snapshot
8.2. Global Human Microbiome Market by Technology, Performance – Potential Analysis
8.3. Global Human Microbiome Market Estimates & Forecasts by Technology 2016-2026 (USD Million)
8.4. Human Microbiome Market, Sub Segment Analysis
8.4.1. Genomics
8.4.2. Proteomics
8.4.3. Metabolomics
Chapter 9. Global Human Microbiome Market, Regional Analysis
9.1. Human Microbiome Market, Regional Market Snapshot
9.2. North America Human Microbiome Market
9.2.1. U.S. Human Microbiome Market
9.2.1.1. Product breakdown estimates & forecasts, 2016-2026
9.2.1.2. Application breakdown estimates & forecasts, 2016-2026
9.2.1.3. Disease breakdown estimates & forecasts, 2016-2026
9.2.1.4. Technology breakdown estimates & forecasts, 2016-2026
9.2.2. Canada Human Microbiome Market
9.3. Europe Human Microbiome Market Snapshot
9.3.1. U.K. Human Microbiome Market
9.3.2. Rest of Europe Human Microbiome Market
9.4. Asia-Pacific Human Microbiome Market Snapshot
9.4.1. China Human Microbiome Market
9.4.2. India Human Microbiome Market
9.4.3. Japan Human Microbiome Market
9.4.4. Rest of Asia Pacific Human Microbiome Market
9.5. Latin America Human Microbiome Market Snapshot
9.5.1. Brazil Human Microbiome Market
9.5.2. Mexico Human Microbiome Market
9.6. Rest of The World Human Microbiome Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Enterome Bioscience
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Seres Therapeutics
10.2.3. 4D Pharma PLC
10.2.4. Ubiome, Inc.
10.2.5. E.I. Du Pont De Nemours and Company
10.2.6. Synlogic
10.2.7. Second Genome
10.2.8. Vedanta Biosciences, Inc.
10.2.9. Ferring Pharmaceuticals
10.2.10. Evelo Biosciences, Inc.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL HUMAN MICROBIOME MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL HUMAN MICROBIOME MARKET
TABLE 3. GLOBAL HUMAN MICROBIOME MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. GLOBAL HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD MILLION)
TABLE 7. GLOBAL HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY PRODUCT 2016-2026 (USD MILLION)
TABLE 8. GLOBAL HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY APPLICATION 2016-2026 (USD MILLION)
TABLE 9. GLOBAL HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY DISEASE 2016-2026 (USD MILLION)
TABLE 10. GLOBAL HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY TECHNOLOGY 2016-2026 (USD MILLION)
TABLE 11. GLOBAL HUMAN MICROBIOME MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 12. GLOBAL HUMAN MICROBIOME MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 13. GLOBAL HUMAN MICROBIOME MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 14. GLOBAL HUMAN MICROBIOME MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 15. GLOBAL HUMAN MICROBIOME MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 16. GLOBAL HUMAN MICROBIOME MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 17. GLOBAL HUMAN MICROBIOME MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 18. GLOBAL HUMAN MICROBIOME MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 19. GLOBAL HUMAN MICROBIOME MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 20. GLOBAL HUMAN MICROBIOME MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 21. GLOBAL HUMAN MICROBIOME MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 22. GLOBAL HUMAN MICROBIOME MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 23. GLOBAL HUMAN MICROBIOME MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 24. GLOBAL HUMAN MICROBIOME MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 25. GLOBAL HUMAN MICROBIOME MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 26. GLOBAL HUMAN MICROBIOME MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 27. GLOBAL HUMAN MICROBIOME MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 28. GLOBAL HUMAN MICROBIOME MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 29. GLOBAL HUMAN MICROBIOME MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 30. GLOBAL HUMAN MICROBIOME MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 31. GLOBAL HUMAN MICROBIOME MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 32. GLOBAL HUMAN MICROBIOME MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 33. U.S. HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 34. U.S. HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 35. U.S. HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 36. U.S. HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 37. U.S. HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 38. CANADA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 39. CANADA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 40. CANADA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 41. CANADA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 42. CANADA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 43. UK HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 44. UK HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 45. UK HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 46. UK HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 47. UK HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 48. GERMANY HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 49. GERMANY HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 50. GERMANY HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 51. GERMANY HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 52. GERMANY HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 53. ROE HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 54. ROE HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 55. ROE HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 56. ROE HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 57. ROE HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 58. CHINA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 59. CHINA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 60. CHINA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 61. CHINA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 62. CHINA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 63. INDIA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 64. INDIA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 65. INDIA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 66. INDIA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 67. INDIA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 68. JAPAN HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 69. JAPAN HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 70. JAPAN HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 71. JAPAN HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 72. JAPAN HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 73. ROAPAC HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 74. ROAPAC HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 75. ROAPAC HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 76. ROAPAC HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 77. ROAPAC HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 78. BRAZIL HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 79. BRAZIL HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 80. BRAZIL HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 81. BRAZIL HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 82. BRAZIL HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 83. MEXICO HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 84. MEXICO HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 85. MEXICO HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 86. MEXICO HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 87. MEXICO HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 88. ROLA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 89. ROLA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 90. ROLA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 91. ROLA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 92. ROLA HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 93. ROW HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 94. ROW HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 95. ROW HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 96. ROW HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 97. ROW HUMAN MICROBIOME MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[ヒトマイクロバイオームの世界市場:製品別(プロバイオティクス、プレバイオティクス、食品、医療食品、診断検査および薬物)、用途別(治療、診断)、疾患別(感染症、炎症性疾患、内分泌および代謝障害、癌およびその他の疾患)、技術別( ゲノミクス、プロテオミクス、メタボロミクス)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆